Renaissance Technologies’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $23.6K | Buy |
|
|||||
|
2024
Q2 | $131K | Buy |
|
|||||
|
2024
Q1 | $152K | Buy |
|
|||||
|
2023
Q4 | $175K | Buy |
|
|||||
|
2023
Q3 | $94K | Buy |
|
|||||
|
2023
Q2 | $99K | Buy |
|
|||||
|
2023
Q1 | $200K | Buy |
|
|||||
|
2022
Q4 | $242K | Sell |
|
|||||
|
2022
Q3 | $874K | Buy |
|
|||||
|
2022
Q2 | $715K | Buy |
|
|||||
|
2022
Q1 | $756K | Buy |
|
|||||
|
2021
Q4 | $855K | Buy |
|
|||||
|
2021
Q3 | $595K | Buy |
|
|||||
|
2021
Q2 | $248K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $483K | Sell |
|
|||||
|
2020
Q3 | $251K | Buy |
|
|||||
|
2020
Q2 | $193K | Buy |
|
|||||
|
2020
Q1 | $80K | Buy |
|
|||||
|
2019
Q4 | $83K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $282K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.17M | Buy |
|
|||||
|
2018
Q1 | $1.3M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $57K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $30K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $356K | Buy |
|